Vulvar Paget disease: A national retrospective cohort study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30458205.
- Also identified by DOI 10.1016/j.jaad.2018.11.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vulvar Paget disease (VPD) is a rare skin disorder that is considered premalignant. To assess the clinical course, treatment schedules, and effect of invasion and treatment on recurrence and survival in patients with VPD. Data on women with VPD were retrieved from the medical files and pathology reports in all Dutch tertiary university medical centers. Disease-free survival and 5-year disease-specific survival were estimated by using Kaplan-Meier curves. Data on 113 patients whose VPD was diagnosed between 1991 and 2016 were analyzed; 77% had noninvasive VPD. Most of the women (65%) underwent a surgical procedure. Recurrences were reported in 40%. Of the women with noninvasive VPD, 8% developed invasion. There were no disease-specific deaths reported in the women with noninvasive VPD. The 5-year disease-specific survival rate was greater than 98% in noninvasive and microinvasive VPD, but significantly worse in invasive VPD (50% [P < .0005]). The main limitations of this study are its retrospective character and the fact that original pathology samples were not available for reassessment. VPD is extremely rare, and the recurrence rates are high. Most patients have noninvasive VPD, which does not affect survival and should be considered a chronic disorder with limited invasive potential. In cases of invasive disease, survival decreases significantly.
Medical subject headings
- Neoplasm Recurrence, Local
- Paget Disease, Extramammary
- Vulvar Neoplasms